| Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis Y Iturria-Medina, RC Sotero, PJ Toussaint, JM Mateos-Pérez, AC Evans Nature communications 7 (1), 11934, 2016 | 1020 | 2016 |
| Definition and description of schizophrenia in the DSM-5 R Tandon, W Gaebel, DM Barch, J Bustillo, RE Gur, S Heckers, ... Schizophrenia research 150 (1), 3-10, 2013 | 1007 | 2013 |
| Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study RG Robinson, SK Schultz, C Castillo, T Kopel, JT Kosier, RM Newman, ... American Journal of Psychiatry 157 (3), 351-359, 2000 | 536 | 2000 |
| Plasma tau in Alzheimer disease N Mattsson, H Zetterberg, S Janelidze, PS Insel, U Andreasson, ... Neurology 87 (17), 1827-1835, 2016 | 488 | 2016 |
| In vivo staging of regional amyloid deposition MJ Grothe, H Barthel, J Sepulcre, M Dyrba, O Sabri, SJ Teipel, ... Neurology 89 (20), 2031-2038, 2017 | 399 | 2017 |
| The initial field trials of DSM-5: new blooms and old thorns R Freedman, DA Lewis, R Michels, DS Pine, SK Schultz, CA Tamminga, ... American Journal of Psychiatry 170 (1), 1-5, 2013 | 381 | 2013 |
| Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future YE Geda, LS Schneider, LN Gitlin, DS Miller, GS Smith, J Bell, J Evans, ... Alzheimer's & dementia 9 (5), 602-608, 2013 | 372 | 2013 |
| Quantitative in vivo measurement of gyrification in the human brain: changes associated with aging VA Magnotta, NC Andreasen, SK Schultz, G Harris, T Cizadlo, D Heckel, ... Cerebral Cortex 9 (2), 151-160, 1999 | 334 | 1999 |
| Structure of the psychotic disorders classification in DSM‐5 S Heckers, DM Barch, J Bustillo, W Gaebel, R Gur, D Malaspina, ... Schizophrenia research 150 (1), 11-14, 2013 | 329 | 2013 |
| Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy. C Salzman, DV Jeste, RE Meyer, J Cohen-Mansfield, J Cummings, ... Journal of Clinical Psychiatry 69 (6), 889-898, 2008 | 311 | 2008 |
| Catatonia in DSM-5 R Tandon, S Heckers, J Bustillo, DM Barch, W Gaebel, RE Gur, ... Schizophrenia research 150 (1), 26-30, 2013 | 306 | 2013 |
| Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE S Ayton, NG Faux, AI Bush Nature communications 6 (1), 6760, 2015 | 300 | 2015 |
| Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects S Gupta, NC Andreasen, S Arndt, M Flaum, SK Schultz, WC Hubbard, ... American Journal of Psychiatry 152 (2), 191-196, 1995 | 296 | 1995 |
| Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology TW Schmitz, R Nathan Spreng Nature communications 7 (1), 13249, 2016 | 293 | 2016 |
| Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5 DM Barch, J Bustillo, W Gaebel, R Gur, S Heckers, D Malaspina, ... Schizophrenia research 150 (1), 15-20, 2013 | 284 | 2013 |
| Capacity to provide informed consent for participation in schizophrenia and HIV research DJ Moser, SK Schultz, S Arndt, ML Benjamin, FW Fleming, CS Brems, ... American Journal of Psychiatry 159 (7), 1201-1207, 2002 | 255 | 2002 |
| Attenuated psychosis syndrome in DSM-5 MT Tsuang, J Van Os, R Tandon, DM Barch, J Bustillo, W Gaebel, RE Gur, ... Schizophrenia research 150 (1), 31-35, 2013 | 235 | 2013 |
| Effects of smoking marijuana on brain perfusion and cognition DS O'Leary, RI Block, JA Koeppel, M Flaum, SK Schultz, NC Andreasen, ... Neuropsychopharmacology 26 (6), 802-816, 2002 | 229 | 2002 |
| Relapse risk after discontinuation of risperidone in Alzheimer's disease DP Devanand, J Mintzer, SK Schultz, HF Andrews, DL Sultzer, ... New England Journal of Medicine 367 (16), 1497-1507, 2012 | 224 | 2012 |
| The life course of schizophrenia: age and symptom dimensions SK Schultz, DD Miller, SE Oliver, S Arndt, M Flaum, NC Andreasen Schizophrenia Research 23 (1), 15-23, 1997 | 211 | 1997 |
